Abiopharma

How to Connect Airpods to iPhone (2025 Guide)

Director Pershing Edward 🟢 acquired 10.5K shares (1 derivative) of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) at $2.86 Transaction Date: Aug 26, 2025 | Filing ID: 025685

Best Noise Cancelling True Wireless Earbuds In 2025

New Form 144 - REVVITY, INC. Filed: 2025-08-27 AccNo: 0002007317-25-000976 Size: 4 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Novavaxs Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

New Form 144 - Amneal Pharmaceuticals, Inc. Filed: 2025-08-27 AccNo: 0002007317-25-000975 Size: 4 KB

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction